Patents by Inventor ADAM SHAYWITZ

ADAM SHAYWITZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240263160
    Abstract: The present disclosure relates in general to therapeutic lysosomal enzyme fusion proteins useful for treating lyso-somal storage diseases, liquid formulations comprising such fusion proteins and associated methods useful for treating lysosomal storage diseases in mammals.
    Type: Application
    Filed: March 19, 2024
    Publication date: August 8, 2024
    Inventors: Saeed Moshashaee, Jason K. Pinkstaff, Adam Shaywitz, Natalie Ciaccio
  • Publication number: 20240191213
    Abstract: Disclosed herein are recombinant adeno-associated viral vectors expressing 21-hydroxy lase (21OH) protein and related uses for treating 21OH deficiency.
    Type: Application
    Filed: March 18, 2022
    Publication date: June 13, 2024
    Inventors: Clayton BEARD, Kamal BHARUCHA, Pierre BOUGNERES, Eric DAVID, Rachel ECLOV, Rafael ESCANDON, Genevieve LAFORET, Adam SHAYWITZ, Sophie LE FUR
  • Publication number: 20220251526
    Abstract: The present disclosure relates in general to therapeutic lysosomal enzyme fusion proteins useful for treating lyso-somal storage diseases, liquid formulations comprising such fusion proteins and associated methods useful for treating lysosomal storage diseases in mammals.
    Type: Application
    Filed: April 25, 2022
    Publication date: August 11, 2022
    Inventors: SAEED MOSHASHAEE, JASON K. PINKSTAFF, ADAM SHAYWITZ, NATALIE CIACCIO
  • Patent number: 11345904
    Abstract: The present disclosure relates in general to therapeutic lysosomal enzyme fusion proteins useful for treating lysosomal storage diseases, liquid formulations comprising such fusion proteins and associated methods useful for treating lysosomal storage diseases in mammals.
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: May 31, 2022
    Assignee: BIOMARIN PHARMACEUTICAL INC.
    Inventors: Saeed Moshashaee, Jason K. Pinkstaff, Adam Shaywitz, Natalie Ciaccio
  • Publication number: 20200297821
    Abstract: The present disclosure relates in general to therapeutic lysosomal enzyme fusion proteins useful for treating lysosomal storage diseases, liquid formulations comprising such fusion proteins and associated methods useful for treating lysosomal storage diseases in mammals.
    Type: Application
    Filed: February 24, 2017
    Publication date: September 24, 2020
    Applicant: BIOMARIN PHARMACEUTICAL INC.
    Inventors: SAEED MOSHASHAEE, JASON K. PINKSTAFF, ADAM SHAYWITZ, NATALIE CIACCIO